Market Overview

Recent Stories

After nearly two years, the U.S. Food & Drug Administration has finally approved the generic versions of the EpiPen produced by Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA).

On CNBC's "Fast Money Halftime Report", Jon Najarian spoke about unusually high options volume in JD.Com Inc(ADR) (NASDAQ: JD) and Dicks Sporting Goods Inc (NYSE:

Tax software maker Avalara Inc (NYSE: AVLR) made an initial public offering of 7.5 million shares at $24 each, with the shares priced on June 15.

Few voices on Wall Street are more respected than that of Berkshire Hathaway, Inc. (NYSE: BRK-A)(NYSE: BRK-B) CEO Warren Buffett.

Kimberly Clark Corp (NYSE: KMB)'s announcement that it's raising prices on a host of key items in North America triggered a sell-side upgrade Thursday. 

Uxin Ltd (ADR) (NASDAQ: UXIN), a Chinese e-commerce platform for used cars, won over a sell-side bull Thursday, with Goldman Sachs identifying three key strengths in the company.

Toward the end of trading Thursday, the Dow traded up 1.71 percent to 25,591.51 while the NASDAQ climbed 0.66 percent to 7,825.61. The S&P also rose, gaining 0.95 percent to 2,845.09.

Tesla Inc (NASDAQ: TSLA) has been the talk of the town on Wall Street in recent weeks, and analysts are weighing in on Tesla and CEO Elon Musk’s controversial proposa

On Friday, Deere & Co (NYSE: DE) will report its last quarter's earnings. Here is Benzinga's take on the company's release.

Earnings and Revenue

Wall Street analysts see Deere & Co reporting earnings of $2.75 per share on sales of $9.21 billion.

A near-term recovery for Coty Inc (NYSE: COTY) seems unlikely, according to a new analyst report.

The Analyst

Bank of America analyst Olivia Tong downgraded Coty from Buy to Underperform and lowered her price target from $16 to $10.